Skip to Content

Straumann Holding AG

STMN: XSWX (CHE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CHF 316.00SsrxcpTgdmxqnk

Despite Omicron and Geopolitical Headwinds, Implant Volume Shows Strong Growth at Straumann

Business Strategy and Outlook

Straumann is a global leader in dental implants, with a dominant position in the premium dental implant market and a growing share of the fragmented non-premium end of the market. The company’s brand is well established and trusted by dental professionals for its high quality and the excellent training and support offered. Furthermore, the technologies behind the company’s premium implants are supported by decades of clinical research and collaboration with academic networks. Given the pickup in demand following COVID-19 disruption to dental offices in 2021, the size of the global dental implant market was in excess of CHF 5 billion. We anticipate the market will continue to grow faster than global GDP due an aging population in premium markets, a growing middle class with disposable income in strategic growth and emerging markets, and increasing interest in dental hygiene and cosmetic procedures.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of STMN so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center